UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

Science translational medicine, 2012-10, Vol.4 (155), p.155ra138

2012

Volltextzugriff (PDF)

Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial

Annals of internal medicine, 2013-01, Vol.158 (1), p.19

2013

Volltextzugriff (PDF)

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus , is safe and immunogenic in healthy adults

Vaccine, 2012-12, Vol.30 (52), p.7594-7600

2012

Volltextzugriff (PDF)

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins

Open forum infectious diseases, 2016-01, Vol.3 (1), p.ofw015-ofw015

2016

Volltextzugriff (PDF)

Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects

Clinical pharmacology in drug development, 2016-03, Vol.5 (2), p.91-101

2016

Volltextzugriff (PDF)

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200

Journal of acquired immune deficiency syndromes (1999), 2010-04, Vol.53 (4), p.491-495

2010

Volltextzugriff (PDF)

Immune response of elderly individuals to a live attenuated varicella vaccine

The Journal of infectious diseases, 1992-08, Vol.166 (2), p.253-259

1992

Volltextzugriff (PDF)

Varicella-Zoster Virus Vaccine

Clinical infectious diseases, 1997-05, Vol.24 (5), p.753-763

White, C. Jo

1997

Volltextzugriff (PDF)

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response

The Pediatric infectious disease journal, 1992-01, Vol.11 (1), p.19-22

1992

Volltextzugriff (PDF)

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

The Journal of infectious diseases, 1994-09, Vol.170 (3), p.522-526

1994

Volltextzugriff (PDF)

Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy Children

The Journal of infectious diseases, 1996-03, Vol.173 (3), p.731-734

1996

Volltextzugriff (PDF)

Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989

Pediatrics (Evanston), 1991-05, Vol.87 (5), p.604

1991

Volltextzugriff (PDF)

NDV-3, a recombinant alum-adjuvanted vaccine forCandidaandStaphylococcus aureus, is safe and immunogenic in healthy adults

Vaccine, 2012-12, Vol.30 (52), p.7594

2012

Volltextzugriff (PDF)

Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses

Science translational medicine, 2012-10, Vol.4 (155)

2012

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX

The Pediatric infectious disease journal, 1998-11, Vol.17 (11), p.980-985

1998

Volltextzugriff (PDF)

Herpes zoster and quality of life: a self-limited disease with severe impact

Neurology, 1995-12, Vol.45 (12 Suppl 8), p.S52

1995

Volltextzugriff (PDF)

Reply

Clinical infectious diseases, 1998-01, Vol.26 (1), p.241-242

White, C. Jo

1998

Volltextzugriff (PDF)

CLINICAL TRIALS OF VARICELLA VACCINE IN HEALTHY CHILDREN

Infectious disease clinics of North America, 1996-09, Vol.10 (3), p.595-608

Jo White, C.

1996

Volltextzugriff (PDF)

Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children

Clinical infectious diseases, 1997-05, Vol.24 (5), p.925-931

1997

Volltextzugriff (PDF)

Morbidity Among Adults with Varicella‐Zoster Virus Infection: Reply

Clinical infectious diseases, 1998-01, Vol.26 (1), p.241-242

White, C. Jo

1998

Volltextzugriff (PDF)

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine

Pediatrics (Evanston), 1993-12, Vol.92 (6), p.833-837

1993

Volltextzugriff (PDF)

Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization

The Journal of infectious diseases, 1995-07, Vol.172 (1), p.217-219

1995

Volltextzugriff (PDF)

Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children

The Journal of infectious diseases, 1996-03, Vol.173 (3), p.731-734

1996

Volltextzugriff (PDF)

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children

The Pediatric infectious disease journal, 1996-01, Vol.15 (1), p.49-54

1996

Volltextzugriff (PDF)

Recombinant Human Interferon-γ Reconstitutes Defective Phagocyte Function in Patients with Chronic Granulomatous Disease of Childhood

Proceedings of the National Academy of Sciences - PNAS, 1988-07, Vol.85 (13), p.4874-4878

1988

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(354)
Mit Volltextzugriff
(316)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(385)
Japanisch
(63)
Deutsch
(2)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus , is safe and immunogenic in healthy adults

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins

Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200

Immune response of elderly individuals to a live attenuated varicella vaccine

Varicella-Zoster Virus Vaccine

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy Children

Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989

NDV-3, a recombinant alum-adjuvanted vaccine forCandidaandStaphylococcus aureus, is safe and immunogenic in healthy adults

Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses

Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX

Herpes zoster and quality of life: a self-limited disease with severe impact

Reply

CLINICAL TRIALS OF VARICELLA VACCINE IN HEALTHY CHILDREN

Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children

Morbidity Among Adults with Varicella‐Zoster Virus Infection: Reply

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine

Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization

Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children

Recombinant Human Interferon-γ Reconstitutes Defective Phagocyte Function in Patients with Chronic Granulomatous Disease of Childhood

Suchergebnisse filtern